These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24872264)

  • 41. Coinfection of hepatitis B and hepatitis delta virus in Belgium: a multicenter BASL study. Prospective epidemiology and comparison with HBV mono-infection.
    Ho E; Deltenre P; Nkuize M; Delwaide J; Colle I; Michielsen P;
    J Med Virol; 2013 Sep; 85(9):1513-7. PubMed ID: 23852675
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya.
    Elzouki AN; Bashir SM; Elahmer O; Elzouki I; Alkhattali F
    Arab J Gastroenterol; 2017 Dec; 18(4):216-219. PubMed ID: 29241726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epidemiology of HDV infection in Japan.
    Mitamura K
    Prog Clin Biol Res; 1991; 364():81-7. PubMed ID: 2020725
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delta virus infection in Jerusalem.
    Schuger L; Bonino F; Mushahwar IK; Ron N; Shouval D
    Isr J Med Sci; 1988 Mar; 24(3):156-9. PubMed ID: 3286578
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.
    Heidrich B; Serrano BC; Idilman R; Kabaçam G; Bremer B; Raupach R; Önder FO; Deterding K; Zacher BJ; Taranta A; Bozkaya H; Zachou K; Tillmann HL; Bozdayi AM; Manns MP; Yurdaydın C; Wedemeyer H
    Liver Int; 2012 Oct; 32(9):1415-25. PubMed ID: 22716112
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of HIV disease on serum markers of hepatitis delta infection in intravenous drug abusers.
    Lake-Bakaar G; Bhat K; Govindarajan S
    J Lab Clin Med; 1994 Oct; 124(4):564-8. PubMed ID: 7930880
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection.
    Sakugawa H; Nakasone H; Nakayoshi T; Kawakami Y; Yamashiro T; Maeshiro T; Kinjo F; Saito A; Zukeran H
    J Med Virol; 2001 Nov; 65(3):478-84. PubMed ID: 11596082
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Higher rate of hepatitis events in patients with human immunodeficiency virus, hepatitis B, and hepatitis D genotype II infection: a cohort study in a medical center in southern Taiwan.
    Lee CY; Tsai HC; Lee SS; Wu KS; Sy CL; Chen JK; Chen YS
    J Microbiol Immunol Infect; 2015 Feb; 48(1):20-7. PubMed ID: 24064291
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDV seroprevalence in HBsAg positive patients.
    Abbasi A; Bhutto AR; Butt N; Mahmood K
    J Coll Physicians Surg Pak; 2014 Sep; 24(9):624-7. PubMed ID: 25233963
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Virological and clinical characteristics of delta hepatitis in Central Europe.
    Heidrich B; Deterding K; Tillmann HL; Raupach R; Manns MP; Wedemeyer H
    J Viral Hepat; 2009 Dec; 16(12):883-94. PubMed ID: 19566789
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of HDV infection in Shandong province].
    Chen X; Xuan M; Yin Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Jun; 19(3):138-40. PubMed ID: 10322728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genotypes and phylogenetic characterization of hepatitis B and delta viruses in Egypt.
    Saudy N; Sugauchi F; Tanaka Y; Suzuki S; Aal AA; Zaid MA; Agha S; Mizokami M
    J Med Virol; 2003 Aug; 70(4):529-36. PubMed ID: 12794714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Seroprevalence of antibody to HDV in Nigerians with hepatitis B virus-related liver diseases.
    Nwokediuko SC; Ijeoma U
    Niger J Clin Pract; 2009 Dec; 12(4):439-42. PubMed ID: 20329688
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus].
    de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U
    Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of hepatitis B surface antigen among patients suspected of liver diseases in a Nigerian hospital.
    Baba MM; Ajayi BB; Ekanem IA
    Niger Postgrad Med J; 2000 Sep; 7(3):91-5. PubMed ID: 11257921
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on seroprevalence of hepatitis delta in a regional hospital in western Turkey.
    Kose S; Ece G; Gozaydin A; Turken M
    J Infect Dev Ctries; 2012 Nov; 6(11):782-5. PubMed ID: 23277503
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HDAg-L variants in covert hepatitis D and HBV occult infection among Amerindians of Argentina: new insights.
    Delfino CM; Eirin ME; Berini C; Malan R; Gentile E; Castillo A; Pedrozo W; Krupp R; Blejer J; Oubiña JR; Mathet VL; Biglione MM
    J Clin Virol; 2012 Jul; 54(3):223-8. PubMed ID: 22608280
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
    Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
    Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.